The mechanisms by which HCV may promote T2D include impairment of the insulin signaling pathway by viral proteins and HCV-induced liver inflammation resulting in the release of pro-inflammatory cytokines and chemokines that interfere with insulin signaling [38]. This evidence concerns the gene INS and Hepatitis.